You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 8, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Zhongming Dai1, Wen Cheng1, Huan Peng1
1Department of Gastroenterology, Qiu District People's Hospital, Shenzhen, Shenzhen, Guangdong, China.
Fecal microbiota transplantation (FMT) is a promising therapy for inflammatory bowel disease (IBD). Donor microbiota composition significantly impacts FMT efficacy, with high-abundance beneficial genera leading to better outcomes in preclinical models.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: